Key result
Concatenated tetramers with alternating Kv7.4 and Kv7.5 alpha-subunits reproduced the unique biophysical and pharmacological characteristics of native smooth muscle M-currents, suggesting a 2:2 stoichiometry in native channels.
Why the study?
It remained unknown how Kv7.4 and Kv7.5 alpha-subunits combine to produce the distinct biophysical, regulatory, and pharmacological characteristics of vascular smooth muscle heteromeric channels.
Heteromeric Kv7.4/Kv7.5 channels with an alternating 2:2 stoichiometry reproduce the biophysical and pharmacological properties of native M-currents in smooth muscle cells.
Answers are grounded in this paper and cite their sources.
Extends models of native M-current composition; leaves open human validation and therapeutic targeting.
Smooth muscle cells of the vasculature, viscera, and lungs generally express multiple α-subunits of the Kv7 voltage-gated potassium channel family, with increasing evidence that both Kv7.4 and Kv7.5 can conduct "M-currents" that are functionally important for the regulation of smooth muscle contractility. Although expression systems demonstrate that functional channels can form as homomeric tetramers of either Kv7.4 or Kv7.5 α-subunits, there is evidence that heteromeric channel complexes, containing some combination of Kv7.4 and Kv7.5 α-subunits, may represent the predominant configuration natively expressed in some arterial myocytes, such as rat mesenteric artery smooth muscle cells (MASMCs). Our previous work has suggested that Kv7.4/Kv7.5 heteromers can be distinguished from Kv7.4 or Kv7.5 homomers based on their biophysical, regulatory, and pharmacological characteristics, but it remains to be determined how Kv7.4 and Kv7.5 α-subunits combine to produce these distinct characteristics. In the present study, we constructed concatenated dimers or tetramers of Kv7.4 and Kv7.5 α-subunits and expressed them in a smooth muscle cell line to determine if a particular α-subunit configuration can exhibit the features previously reported for natively expressed Kv7 currents in MASMCs. Several unique characteristics of native smooth muscle M-currents were reproduced under conditions that constrain channel formation to a Kv7.4:Kv7.5 stoichiometry of 2:2, with alternating Kv7.4 and Kv7.5 α-subunits within a tetrameric structure. Although other subunit arrangements/combinations are not ruled out, the findings provide new insights into the oligomerization of α-subunits and the ways in which Kv7.4/Kv7.5 subunit assembly can affect smooth muscle signal transduction and pharmacological responses to Kv7 channel modulating drugs.
No takes yet. Share an insight, caveat, or question.
Brueggemann et al. (2020) studied Smooth muscle M-currents (in vitro). Concatenated Kv7.4 and Kv7.5 alpha-subunit constructs (dimers and tetramers) vs. Co-expressed individual Kv7.4 and Kv7.5 alpha-subunits was evaluated on Voltage of half-maximal activation (V0.5) and current amplitude responses to pharmacological agents. Concatenated tetramers with alternating Kv7.4 and Kv7.5 alpha-subunits reproduced the unique biophysical and pharmacological characteristics of native smooth muscle M-currents, suggesting a 2:2 stoichiometry in native channels.
Synapse has enriched 10 related papers. Consider them for comparative context: